249 related articles for article (PubMed ID: 31026503)
1. Quinidine-A legacy within the modern era of antiarrhythmic therapy.
Vitali Serdoz L; Rittger H; Furlanello F; Bastian D
Pharmacol Res; 2019 Jun; 144():257-263. PubMed ID: 31026503
[TBL] [Abstract][Full Text] [Related]
2. The Role of Quinidine in the Pharmacological Therapy of Ventricular Arrhythmias 'Quinidine'.
Bozic B; Uzelac TV; Kezic A; Bajcetic M
Mini Rev Med Chem; 2018; 18(6):468-475. PubMed ID: 28685701
[TBL] [Abstract][Full Text] [Related]
3. Quinidine revisited.
Yang F; Hanon S; Lam P; Schweitzer P
Am J Med; 2009 Apr; 122(4):317-21. PubMed ID: 19249010
[TBL] [Abstract][Full Text] [Related]
4. Challenge and Impact of Quinidine Access in Sudden Death Syndromes: A National Experience.
Malhi N; Cheung CC; Deif B; Roberts JD; Gula LJ; Green MS; Pang B; Sultan O; Konieczny KM; Angaran P; Dorian P; Lashevsky I; Healey JS; Alak A; Tadros R; Andorin A; Steinberg C; Ayala-Paredes F; Simpson CS; Atallah J; Krahn AD
JACC Clin Electrophysiol; 2019 Mar; 5(3):376-382. PubMed ID: 30898241
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy in inherited and acquired ventricular arrhythmia in structurally normal adult hearts.
Ortmans S; Daval C; Aguilar M; Compagno P; Cadrin-Tourigny J; Dyrda K; Rivard L; Tadros R
Expert Opin Pharmacother; 2019 Dec; 20(17):2101-2114. PubMed ID: 31566420
[No Abstract] [Full Text] [Related]
6. Quinidine: a valuable medication joins the list of 'endangered species'.
Viskin S; Antzelevitch C; Márquez MF; Belhassen B
Europace; 2007 Dec; 9(12):1105-6. PubMed ID: 17761793
[No Abstract] [Full Text] [Related]
7. J wave elevation to monitor quinidine efficacy in early repolarization syndrome.
Sacher F; Derval N; Horlitz M; Haïssaguerre M
J Electrocardiol; 2014; 47(2):223-5. PubMed ID: 24332747
[TBL] [Abstract][Full Text] [Related]
8. Management of Brugada Syndrome: Thirty-Three-Year Experience Using Electrophysiologically Guided Therapy With Class 1A Antiarrhythmic Drugs.
Belhassen B; Rahkovich M; Michowitz Y; Glick A; Viskin S
Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1393-402. PubMed ID: 26354972
[TBL] [Abstract][Full Text] [Related]
9. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
10. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome.
Belhassen B; Glick A; Viskin S
Pacing Clin Electrophysiol; 2009 Mar; 32(3):294-301. PubMed ID: 19272057
[TBL] [Abstract][Full Text] [Related]
11. Arrhythmic storm responsive to quinidine in a patient with Brugada syndrome and vasovagal syncope.
Márquez MF; Rivera J; Hermosillo AG; Iturralde P; Colín L; Moragrega JL; Cárdenas M
Pacing Clin Electrophysiol; 2005 Aug; 28(8):870-3. PubMed ID: 16105018
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy.
Haïssaguerre M; Sacher F; Nogami A; Komiya N; Bernard A; Probst V; Yli-Mayry S; Defaye P; Aizawa Y; Frank R; Mantovan R; Cappato R; Wolpert C; Leenhardt A; de Roy L; Heidbuchel H; Deisenhofer I; Arentz T; Pasquié JL; Weerasooriya R; Hocini M; Jais P; Derval N; Bordachar P; Clémenty J
J Am Coll Cardiol; 2009 Feb; 53(7):612-619. PubMed ID: 19215837
[TBL] [Abstract][Full Text] [Related]
13. High efficacy of disopyramide in the management of ventricular fibrillation storms in a patient with Brugada syndrome.
Sumi S; Maruyama S; Shiga Y; Kodama S; Miyoshi K; Tojou H; Yamanouchi Y; Urata H
Pacing Clin Electrophysiol; 2010 Jun; 33(6):e53-6. PubMed ID: 20059716
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of quinidine in high-risk patients with Brugada syndrome.
Belhassen B; Glick A; Viskin S
Circulation; 2004 Sep; 110(13):1731-7. PubMed ID: 15381640
[TBL] [Abstract][Full Text] [Related]
15. A phenotypic combination of idiopathic VF and Brugada syndrome.
Martinek M; Purerfellner H
Pacing Clin Electrophysiol; 2010 Sep; 33(9):e84-7. PubMed ID: 20230473
[TBL] [Abstract][Full Text] [Related]
16. Stop "Early repolarization syndrome", start "Haissaguerre syndrome".
Kukla P
J Electrocardiol; 2014; 47(2):226-7. PubMed ID: 24440314
[No Abstract] [Full Text] [Related]
17. Quinidine for the management of electrical storm in an old patient with Brugada syndrome and syncope.
Pellegrino PL; Di Biase M; Brunetti ND
Acta Cardiol; 2013 Apr; 68(2):201-3. PubMed ID: 23705565
[TBL] [Abstract][Full Text] [Related]
18. Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countries.
Viskin S; Wilde AA; Guevara-Valdivia ME; Daoulah A; Krahn AD; Zipes DP; Halkin A; Shivkumar K; Boyle NG; Adler A; Belhassen B; Schapachnik E; Asrar F; Rosso R
J Am Coll Cardiol; 2013 Jun; 61(23):2383-7. PubMed ID: 23583244
[TBL] [Abstract][Full Text] [Related]
19. Electrical storm in Brugada syndrome successfully treated with orciprenaline; effect of low-dose quinidine on the electrocardiogram.
Kyriazis K; Bahlmann E; van der Schalk H; Kuck KH
Europace; 2009 May; 11(5):665-6. PubMed ID: 19346290
[TBL] [Abstract][Full Text] [Related]
20. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.
Mizusawa Y; Sakurada H; Nishizaki M; Hiraoka M
J Cardiovasc Pharmacol; 2006 Mar; 47(3):359-64. PubMed ID: 16633076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
